|1.||Zilker, Thomas: 3 articles (03/2009 - 02/2005)|
|2.||Felgenhauer, Norbert: 3 articles (03/2009 - 02/2005)|
|3.||Rapior, Sylvie: 2 articles (06/2010 - 01/2002)|
|4.||Ganzert, Martin: 2 articles (09/2007 - 02/2005)|
|5.||Lacombe, Guillaume: 1 article (01/2016)|
|6.||St-Onge, Maude: 1 article (01/2016)|
|7.||Guler, Kerim: 1 article (09/2015)|
|8.||Kaya, Ertugrul: 1 article (09/2015)|
|9.||Akata, Ilgaz: 1 article (09/2015)|
|10.||Kose, Murat: 1 article (09/2015)|
06/01/2007 - "Our experience indicates that the protocol used in our Toxicologicy Unit is effective for amatoxin poisoning, and that all patients treated within 36 hours after mushroom ingestion were cured without sequelae."
09/01/2006 - "Finally, is any modality of extracorporeal treatment useful in the treatment of amatoxin poisoning? "
04/01/2011 - "RESULTS. A total of 144 amatoxin poisoning patients were included in this study. "
06/15/2010 - "The aim of the present study is to perform a retrospective multidimensional multivariate statistic analysis of 2110 amatoxin poisoning clinical cases, in order to optimize therapeutic decision-making. "
01/01/2004 - "Among 61 patients included in the study, amatoxin poisoning was diagnosed in 10 cases. "
|2.||Acute Liver Failure (Fulminant Hepatic Failure)
06/01/2001 - "The purpose of this study was to develop a clinically relevant porcine model of fulminant hepatic failure (FHF) by means of administration of amatoxin and endotoxin. "
10/01/2014 - "Acute liver failure due to ingestion of amatoxin-containing mushrooms is a relatively rare entity. "
06/01/2001 - "Increased intracranial pressure in a porcine model of fulminant hepatic failure using amatoxin and endotoxin."
02/01/2005 - "Indication of liver transplantation in acute liver failure following amatoxin intoxication is still uncertain. "
06/10/2011 - "Amatoxin poisoning induces a delayed onset of acute liver failure which might be explained by the prolonged persistence of the toxin in the enterohepatic circulation. "
04/01/2011 - "CONCLUSIONS. The factors associated with mortality determined in this retrospective study may be helpful for clinical outcome assessment and monitoring of patients with amatoxin-containing mushroom poisoning."
08/01/2012 - "More than 90% of all fatal mushroom poisonings worldwide are due to amatoxin containing species that grow abundantly in Europe, South Asia, and the Indian subcontinent. "
04/01/2011 - "OBJECTIVE. We aimed to determine clinical and laboratory findings that were different between those patients who died and those who survived and to look for factors associated with the mortality in amatoxin-containing mushroom poisoning. "
04/01/2011 - "Clinical features and outcome of patients with amatoxin-containing mushroom poisoning."
06/01/2007 - "Fatalities due to mushroom poisonings are increasing worldwide, with more than 90% of deaths resulting from ingestion of amatoxin-containing species. "
06/01/1991 - "Despite consistent improvement in its treatment, amatoxin poisoning still extolls an elevated overall mortality, ranging between 10 and 15%, which approaches 100% when severe (grade 3-4 encephalopathy) hepatic failure supervened. "
09/01/2007 - "Four of the patients in whose blood amatoxin was detected (50%) and 3 of the patients highly suggestive of amanita poisoning (30%), totally 7 patients died of hepatic coma. "
01/01/2002 - "Amatoxin poisoning is a medical emergency characterized by a long incubation time lag, gastrointestinal and hepatotoxic phases, coma, and death. "
06/01/1991 - "Despite they did not receive liver transplantation, both patients wakened from coma, their liver function improved, and they recovered from terminal amatoxin poisoning. "
|3.||RNA Polymerase II (RNA Polymerase B)
|4.||Penicillin G (Benzylpenicillin)
|8.||Sulfobromophthalein (Sulfobromophthalein Sodium)
|2.||Investigational Therapies (Experimental Therapy)